AI Article Synopsis

  • Mutations in the LRRK2 gene are linked to familial Parkinson's disease, with the protein having important interaction domains at both its ends.
  • This study used microscopy and assays to find that the N- and C-terminal domains of LRRK2 affect synaptic vesicle movement in opposing ways and bind to different proteins.
  • The G2385R variant in the C-terminal domain increases Parkinson's risk by altering protein interactions and synaptic vesicle fusion, potentially leading to impaired vesicular trafficking and disease progression.

Article Abstract

Mutations in the Leucine-rich repeat kinase 2 gene (LRRK2) are associated with familial Parkinson's disease (PD). LRRK2 protein contains several functional domains, including protein-protein interaction domains at its N- and C-termini. In this study, we analyzed the functional features attributed to LRRK2 by its N- and C-terminal domains. We combined TIRF microscopy and synaptopHluorin assay to visualize synaptic vesicle trafficking. We found that N- and C-terminal domains have opposite impact on synaptic vesicle dynamics. Biochemical analysis demonstrated that different proteins are bound at the two extremities, namely β3-Cav2.1 at N-terminus part and β-Actin and Synapsin I at C-terminus domain. A sequence variant (G2385R) harboured within the C-terminal WD40 domain increases the risk for PD. Complementary biochemical and imaging approaches revealed that the G2385R variant alters strength and quality of LRRK2 interactions and increases fusion of synaptic vesicles. Our data suggest that the G2385R variant behaves like a loss-of-function mutation that mimics activity-driven events. Impaired scaffolding capabilities of mutant LRRK2 resulting in perturbed vesicular trafficking may arise as a common pathophysiological denominator through which different LRRK2 pathological mutations cause disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511190PMC
http://dx.doi.org/10.1038/s41598-017-05760-9DOI Listing

Publication Analysis

Top Keywords

g2385r variant
12
synaptic vesicle
12
loss-of-function mutation
8
vesicle trafficking
8
c-terminal domains
8
lrrk2
7
lrrk2 g2385r
4
variant
4
variant partial
4
partial loss-of-function
4

Similar Publications

Objective: We established a prospective cohort study to investigate the differences in motor and non-motor symptoms between idiopathic Parkinson's disease (IPD) and Parkinson's disease in carriers of leucine-rich repeat kinase 2 (LRRK2) gene risk variants (LRRK2-PD).

Methods: The study included 1407 individuals with IPD and 649 individuals with LRRK2-PD (comprising 304 with LRRK2-G2385R, 220 with LRRK2-R1628P, and 105 with LRRK2-A419V). Differences in symptoms between LRRK2-PD and IPD were analyzed using LCMM modeling and Cox regression analysis.

View Article and Find Full Text PDF
Article Synopsis
  • This study explores the role of structural variants, copy number variants, and short tandem repeats in Parkinson's disease by analyzing data from 466 PD patients and 513 controls.
  • The researchers identified tens of thousands of genetic variations and found that certain CNV deletions were more common in PD patients, particularly at the ends of autosomal chromosomes.
  • They confirmed specific deletions near the MUC19 and RXFP1 genes, along with certain repeat variants in SLC2A13, were significantly linked to PD and may affect the severity of other genetic risk factors like the LRRK2 G2385R variant.
View Article and Find Full Text PDF

Alpha-synuclein (α-syn) pathology is the hallmark of Parkinson's disease (PD). The leucine-rich repeat kinase 2 () gene is a major-effect risk gene for sporadic PD (sPD). However, what environmental factors may trigger the formation of α-syn pathology in carriers of risk variants are still unknown.

View Article and Find Full Text PDF
Article Synopsis
  • - The study conducted a genome-wide association study (GWAS) on Parkinson's disease (PD) specific to the Korean population, including 1050 patients and 5000 controls, to explore ethnicity and sex-related genetic factors.
  • - Key findings revealed nine single nucleotide polymorphisms (SNPs) associated with PD, particularly in the SNCA and PARK16 loci; however, significant associations varied between genders, with notable SNPs identified in females and a strong but inconclusive marker in males.
  • - Results indicate that genetic contributions to sporadic PD differ by ethnicity and sex, highlighting the importance of tailored research to understand the disease's genetic background across diverse populations.
View Article and Find Full Text PDF
Article Synopsis
  • Parkinson's disease (PD) is a brain disorder affecting about 7 million people, with genetics playing a big role in some cases, especially in European people.
  • Most research has been done on people of European descent, leaving a gap in understanding how PD affects other groups.
  • To improve research and create new treatments, scientists have formed a global network of 59 research centers and developed tools like an online map to share information and resources with each other.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!